Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
Rangering i aksjer #41057
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Aksjekurs
$0.00285747
Markedsverdi
$47.76K
Endring (1 dag)
-16.00%
Endring (1 år)
-59.77%
Land
GB
Handel Verici Dx plc (VRCI)

Kategori

Utbytteavkastning for Verici Dx plc (VRCI)
Verici Dx plc (aksjesymbol: VRCI) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Verici Dx plc (VRCI) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter